Blood Sugar and Fibrinogen Levels Affect Heart Blood Flow During PCI
Author Information
Author(s): Zufei Wu, Wentao Su, Chen Shi, Xu Bai Da, Zong Gang Jun, Wu Gang-Yong
Primary Institution: The 904th Hospital of the PLA Joint Logistics Support Force
Hypothesis
Do admission blood glucose and fibrinogen levels affect coronary blood flow during primary PCI for acute STEMI?
Conclusion
Elevated admission blood glucose and fibrinogen levels can predict slow blood flow during primary PCI, with their combined diagnostic value being superior to that of either indicator alone.
Supporting Evidence
- Patients with slow blood flow had significantly higher levels of admission blood glucose and fibrinogen compared to the control group.
- Multivariate logistic regression analysis indicated that both admission blood glucose and fibrinogen were independent risk factors for slow blood flow during PCI.
- ROC curve analysis showed that the combination of admission blood glucose and fibrinogen had a higher predictive value for slow blood flow than either alone.
Takeaway
High blood sugar and fibrinogen levels can slow down blood flow in the heart during treatment for a heart attack, and checking both can help doctors predict this problem better.
Methodology
A retrospective analysis of 497 patients who underwent primary PCI for STEMI, divided into slow flow and control groups, with logistic regression and ROC curve analysis performed.
Limitations
The study primarily used TIMI blood flow as the criterion for defining slow flow, which is somewhat subjective, and only single preoperative blood sample tests were conducted.
Participant Demographics
497 patients, average age 59 years, 366 males and 131 females.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%CI 0.754–0.848
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website